MedPath
FDA Approval

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 5, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Braintree Laboratories, Inc.

Affordable Pharmaceuticals, LLC

617357954

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE

Product Details

NDC Product Code
10572-012
Application Number
NDA022372
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
July 5, 2022
SUCRALOSEInactive
Code: 96K6UQ3ZD4Class: IACT
MALIC ACIDInactive
Code: 817L1N4CKPClass: IACT
Code: 1K573LC5TVClass: ACTIBQuantity: 3.13 g in 1 mL
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
Code: 0YPR65R21JClass: ACTIBQuantity: 17.5 g in 1 mL
Code: DE08037SABClass: ACTIBQuantity: 1.6 g in 1 mL

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE

Product Details

NDC Product Code
10572-112
Application Number
NDA022372
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
July 5, 2022
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4Class: IACT
MALIC ACIDInactive
Code: 817L1N4CKPClass: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
Code: 0YPR65R21JClass: ACTIBQuantity: 13.13 g in 133.1 mL
Code: 1K573LC5TVClass: ACTIBQuantity: 2.35 g in 133.1 mL
Code: DE08037SABClass: ACTIBQuantity: 1.2 g in 133.1 mL
© Copyright 2025. All Rights Reserved by MedPath